Agilent Technologies, Inc. and SomaLogic, Inc. have entered into an agreement to expand access to SomaLogic’s unbiased protein biomarker discovery platform. The companies will initially place SomaLogic’s SOMAscan proteomic assay, which employs custom Agilent microarrays in its workflow, in select academic and contract research centers. Terms of the agreement were not disclosed.   “This agreement will greatly enhance our current microarray offerings by expanding them into the rapidly growing prot...